Metástasis cerebral y sobrevida

Background: Brain metastases are the most common cerebral tumors, have a poor prognosis and their incidence is five times higher than primary brain tumors. Aim: To analyze the survival of patients with the diagnosis of brain metastases, operated in our institution. Patients and methods: We retrospec...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lovo I,Eduardo, Torrealba M,Gonzalo, Villanueva G,Pablo, Gejman,Roger, Tagle M,Patricio
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2005
Materias:	Brain neoplasms Cranial irradiation Neoplasms, brain, malignant Neoplasm metastasis
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000200006
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872005000200006
record_format	dspace
spelling	oai:scielo:S0034-988720050002000062005-04-12Metástasis cerebral y sobrevidaLovo I,EduardoTorrealba M,GonzaloVillanueva G,PabloGejman,RogerTagle M,Patricio Brain neoplasms Cranial irradiation Neoplasms, brain, malignant Neoplasm metastasis Background: Brain metastases are the most common cerebral tumors, have a poor prognosis and their incidence is five times higher than primary brain tumors. Aim: To analyze the survival of patients with the diagnosis of brain metastases, operated in our institution. Patients and methods: We retrospectively reviewed all patients operated from January 1989 to December 2001, whose pathological diagnosis confirmed the presence of cerebral metastases. The death date of each patient was obtained from the analysis of death certificates, obtained from the computerized National Registry. Results: In 46 operated patients, the date of death was determined. In 23 of them, information about primary site of malignancy, type of surgery performed and adjunctive treatment with Holocerebral Radiotherapy (Rt) was obtained. The overall median survival time of the 46 patients was 29 weeks (range 4207). Thirty percent of patients were alive one year after surgery. Among those patients with complete clinical information, the median survival of 16 patients who received postoperative Rt was 41 weeks (range 12207), compared to a survival of 18 weeks (range 872), among those that did not receive Rt (p = 0.04). Conclusions: The median survival for patients operated for cerebral metastases in our institution is 29 weeks. Those who are operated and receive Rt, have a longer survival, than those who did not receive Rt (Rev Méd Chile 2005; 133: 190-4)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.2 20052005-02-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000200006es10.4067/S0034-98872005000200006
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Brain neoplasms Cranial irradiation Neoplasms, brain, malignant Neoplasm metastasis
spellingShingle	Brain neoplasms Cranial irradiation Neoplasms, brain, malignant Neoplasm metastasis Lovo I,Eduardo Torrealba M,Gonzalo Villanueva G,Pablo Gejman,Roger Tagle M,Patricio Metástasis cerebral y sobrevida
description	Background: Brain metastases are the most common cerebral tumors, have a poor prognosis and their incidence is five times higher than primary brain tumors. Aim: To analyze the survival of patients with the diagnosis of brain metastases, operated in our institution. Patients and methods: We retrospectively reviewed all patients operated from January 1989 to December 2001, whose pathological diagnosis confirmed the presence of cerebral metastases. The death date of each patient was obtained from the analysis of death certificates, obtained from the computerized National Registry. Results: In 46 operated patients, the date of death was determined. In 23 of them, information about primary site of malignancy, type of surgery performed and adjunctive treatment with Holocerebral Radiotherapy (Rt) was obtained. The overall median survival time of the 46 patients was 29 weeks (range 4207). Thirty percent of patients were alive one year after surgery. Among those patients with complete clinical information, the median survival of 16 patients who received postoperative Rt was 41 weeks (range 12207), compared to a survival of 18 weeks (range 872), among those that did not receive Rt (p = 0.04). Conclusions: The median survival for patients operated for cerebral metastases in our institution is 29 weeks. Those who are operated and receive Rt, have a longer survival, than those who did not receive Rt (Rev Méd Chile 2005; 133: 190-4)
author	Lovo I,Eduardo Torrealba M,Gonzalo Villanueva G,Pablo Gejman,Roger Tagle M,Patricio
author_facet	Lovo I,Eduardo Torrealba M,Gonzalo Villanueva G,Pablo Gejman,Roger Tagle M,Patricio
author_sort	Lovo I,Eduardo
title	Metástasis cerebral y sobrevida
title_short	Metástasis cerebral y sobrevida
title_full	Metástasis cerebral y sobrevida
title_fullStr	Metástasis cerebral y sobrevida
title_full_unstemmed	Metástasis cerebral y sobrevida
title_sort	metástasis cerebral y sobrevida
publisher	Sociedad Médica de Santiago
publishDate	2005
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000200006
work_keys_str_mv	AT lovoieduardo metastasiscerebralysobrevida AT torrealbamgonzalo metastasiscerebralysobrevida AT villanuevagpablo metastasiscerebralysobrevida AT gejmanroger metastasiscerebralysobrevida AT taglempatricio metastasiscerebralysobrevida
_version_	1718436189394960384

Metástasis cerebral y sobrevida

Ejemplares similares